Impact of donor age and year of transplant on graft survival in liver transplant recipients with chronic hepatitis C

被引:43
作者
Russo, MW [1 ]
Galanko, JA
Zacks, SL
Beavers, KL
Fried, MW
Shrestha, R
机构
[1] Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA
[2] Univ N Carolina, Ctr Gastrointestinal Biol & Dis, Chapel Hill, NC USA
关键词
alcohal; cholestatic; organ;
D O I
10.1111/j.1600-6143.2004.00470.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Studies suggest donor age and year of transplantation are associated with low graft survival in liver transplant recipients with hepatitis C. We sought to determine if advanced donor age and recent year of transplantation are associated with graft survival in hepatitis C recipients and to determine if the effect of donor age on graft survival is specific to hepatitis C. We analyzed the United Network for Organ Sharing liver transplant database from 1994 to 2002. Six thousand four hundred and four subjects transplanted for end-stage liver disease from chronic hepatitis C met our criteria. One-year graft survival in hepatitis C recipients with organs from donors <40 years old and greater than or equal to60 years old was 84% and 73%, p = 0.003, respectively. These rates in recipients with cholestatic liver disease and alcoholic liver disease were 85% and 82%, respectively, p = 0.11 and 82% and 78%, respectively, p = 0.14. Three-year graft survival in hepatitis C recipients transplanted from 1994 to 1995 and 1996 to 1999 was 67% and 69%, respectively, p = 0.10. Graft survival in hepatitis C recipients has not declined in recent years. Older donor age is associated with lower short-term graft survival in recipients with hepatitis C, but not in recipients with cholestatic or alcoholic liver disease.
引用
收藏
页码:1133 / 1138
页数:6
相关论文
共 27 条
  • [11] The association between hepatitis C infection and survival after orthotopic liver transplantation
    Forman, LM
    Lewis, JD
    Berlin, JA
    Feldman, HI
    Lucey, MR
    [J]. GASTROENTEROLOGY, 2002, 122 (04) : 889 - 896
  • [12] Pretransplant model to predict posttransplant survival in liver transplant patients
    Ghobrial, RM
    Gornbein, J
    Steadman, R
    Danino, N
    Markmann, JF
    Holt, C
    Anselmo, D
    Amersi, F
    Chen, P
    Farmer, DG
    Han, S
    Derazo, F
    Saab, S
    Goldstein, LI
    McDiarmid, SV
    Busuttil, RW
    [J]. ANNALS OF SURGERY, 2002, 236 (03) : 315 - 323
  • [13] Orthotopic liver transplantation for hepatitis C - Outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience
    Ghobrial, RM
    Farmer, DG
    Baquerizo, A
    Colquhoun, S
    Rosen, HR
    Yersiz, H
    Markmann, JF
    Drazan, KE
    Holt, C
    Imagawa, D
    Goldstein, LI
    Martin, P
    Busuttil, RW
    [J]. ANNALS OF SURGERY, 1999, 229 (06) : 824 - 831
  • [14] Donor age and outcome of liver transplantation
    Hoofnagle, JH
    Lombardero, M
    Zetterman, RK
    Lake, J
    Porayko, M
    Everhart, J
    Belle, SH
    Detre, KM
    [J]. HEPATOLOGY, 1996, 24 (01) : 89 - 96
  • [15] Histological recurrence and progression of hepatitis C after orthotopic liver transplantation: Influence of immunosuppressive regimens
    Hunt, J
    Gordon, FD
    Lewis, WD
    Pomfret, E
    Pomposelli, JJ
    Jenkins, RL
    Khettry, U
    [J]. LIVER TRANSPLANTATION, 2001, 7 (12) : 1056 - 1063
  • [16] Growth-related signaling regulates activation of telomerase in regenerating hepatocytes
    Inui, T
    Shinomiya, N
    Fukasawa, M
    Kobayashi, M
    Kuranaga, N
    Ohkura, S
    Seki, S
    [J]. EXPERIMENTAL CELL RESEARCH, 2002, 273 (02) : 147 - 156
  • [17] A prospective randomized trial of mycophenolate mofetil in liver transplant recipients with hepatitis C
    Jain, A
    Kashyap, R
    Demetris, AJ
    Eghstesad, B
    Pokharna, R
    Fung, JJ
    [J]. LIVER TRANSPLANTATION, 2002, 8 (01) : 40 - 46
  • [18] Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis
    Mazzaferro, V
    Regalia, E
    Doci, R
    Andreola, S
    Pulvirenti, A
    Bozzetti, F
    Montalto, F
    Ammatuna, M
    Morabito, A
    Gennari, L
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (11) : 693 - 699
  • [19] Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation
    Nelson, DR
    Soldevila-Pico, C
    Reed, A
    Abdelmalek, MF
    Hemming, AW
    Van der Werf, WJ
    Howard, R
    Davis, GL
    [J]. LIVER TRANSPLANTATION, 2001, 7 (12) : 1064 - 1070
  • [20] Hepatitis C: Magnitude of the problem
    Rakela, J
    Vargas, HE
    [J]. LIVER TRANSPLANTATION, 2002, 8 (10) : S3 - S6